Literature DB >> 29076429

Salvianolate Blocks Apoptosis During Myocardial Infarction by Down Regulating miR-122-5p.

Jingyang Lin1, Xiaochun Zheng2.   

Abstract

BACKGROUND: Recent studies have provided evidence that microRNAs (miRNAs), as a potential biomarker, were involved in the regulation of gene expression in Myocardial Infarction (MI). This study aimed to highlight the role of salvianolate on cardiomyocyte apoptosis in MI.
METHODS: Anterior descending branch of left coronary artery was ligated to set up MI model. MiR- 122-5p mimic was transfected into cardiomyocytes and verified by quantitative real-time PCR (qRT-PCR). Cell viability and apoptotic rate were measured by MTT assay and flow cytometry together with TUNEL method, respectively. Changes in the expression of caspase-3, Bax and Bcl-2 were quantified by qRT-PCR and western blot.
RESULTS: After treatment with salvianolate, miR-122-5p expression and caspases-3 activity significantly decreased in rat myocardial tissues. Furthermore, cardiomyocytes apoptosis rate was obviously suppressed while cell viability dramatically increased in H9C2 cardiomyocytes. However, overexpression of miR-122-5p reversed the aforementioned trends. Simultaneously, it could also mitigate the anti-apoptosis effect of salvianolate on the upregulation of caspases-3 viability and Bax expression and downregulation of Bcl-2 expression.
CONCLUSION: Salvianolate induces the anti-apoptosis mechanism of cardiomyocytes via downregulation of miR-122-5p, Bax expression and caspases-3 as well as upregulation of Bcl-2 expression. In contrast, overexpression of miR-122-5p inhibits the effect of salvianolate. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Bax; Bcl-2; apoptosis; caspases-3; miR-122-5p; salvianolate

Mesh:

Substances:

Year:  2017        PMID: 29076429     DOI: 10.2174/1567202614666171026114630

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  5 in total

1.  MiR-122-5p suppresses neuropathic pain development by targeting PDK4.

Authors:  Lanlan Wan; Zhen Su; Fayin Li; Pengfei Gao; Xianlong Zhang
Journal:  Neurochem Res       Date:  2021-02-10       Impact factor: 3.996

2.  Reduction of miR-29a-3p induced cardiac ischemia reperfusion injury in mice via targeting Bax.

Authors:  Liang Zhang; Jian Zhang; Qiguang Tong; Guannan Wang; Hongling Dong; Zhonglu Wang; Qi Sun; Hangyu Wu
Journal:  Exp Ther Med       Date:  2019-07-01       Impact factor: 2.447

Review 3.  Advances in Research on the circRNA-miRNA-mRNA Network in Coronary Heart Disease Treated with Traditional Chinese Medicine.

Authors:  Fei Lin; Heng-Wen Chen; Guo-An Zhao; Yan Li; Xuan-Hui He; Wan-Qian Liang; Zhuo-Lin Shi; Si-Yu Sun; Pan-Pan Tian; Ming-Yan Huang; Chao Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-17       Impact factor: 2.629

Review 4.  Roles of MicroRNA-122 in Cardiovascular Fibrosis and Related Diseases.

Authors:  Ying Liu; Jia-Wei Song; Jian-Yu Lin; Ran Miao; Jiu-Chang Zhong
Journal:  Cardiovasc Toxicol       Date:  2020-08-27       Impact factor: 3.231

5.  Inhibition of micro RNA miR-122-5p prevents lipopolysaccharide-induced myocardial injury by inhibiting oxidative stress, inflammation and apoptosis via targeting GIT1.

Authors:  Wenliang Song; Tiening Zhang; Ni Yang; Tao Zhang; Ri Wen; Chunfeng Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.